GIORDANO, Paola
 Distribuzione geografica
Continente #
NA - Nord America 14.679
EU - Europa 6.921
AS - Asia 2.557
SA - Sud America 411
AF - Africa 22
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 3
Totale 24.601
Nazione #
US - Stati Uniti d'America 14.643
DE - Germania 1.456
CN - Cina 1.321
IT - Italia 1.272
SE - Svezia 993
SG - Singapore 911
RU - Federazione Russa 837
FR - Francia 828
UA - Ucraina 510
FI - Finlandia 408
BR - Brasile 370
GB - Regno Unito 363
IE - Irlanda 72
IN - India 61
BE - Belgio 52
KR - Corea 42
HK - Hong Kong 38
AT - Austria 25
ID - Indonesia 24
NL - Olanda 23
CA - Canada 20
VN - Vietnam 20
TR - Turchia 14
AR - Argentina 13
CZ - Repubblica Ceca 13
IQ - Iraq 13
IR - Iran 13
UZ - Uzbekistan 13
PK - Pakistan 11
VE - Venezuela 10
ES - Italia 9
IL - Israele 9
LT - Lituania 9
MX - Messico 9
BD - Bangladesh 8
PT - Portogallo 8
TH - Thailandia 8
AE - Emirati Arabi Uniti 7
RO - Romania 7
ZA - Sudafrica 6
AZ - Azerbaigian 5
JP - Giappone 5
NZ - Nuova Zelanda 5
PL - Polonia 5
SK - Slovacchia (Repubblica Slovacca) 5
BY - Bielorussia 4
EC - Ecuador 4
GE - Georgia 4
PE - Perù 4
PY - Paraguay 4
TW - Taiwan 4
AU - Australia 3
CH - Svizzera 3
CL - Cile 3
DZ - Algeria 3
EU - Europa 3
GR - Grecia 3
JM - Giamaica 3
MA - Marocco 3
PH - Filippine 3
AM - Armenia 2
BG - Bulgaria 2
CO - Colombia 2
CR - Costa Rica 2
EG - Egitto 2
HR - Croazia 2
KZ - Kazakistan 2
LK - Sri Lanka 2
MY - Malesia 2
NO - Norvegia 2
OM - Oman 2
PS - Palestinian Territory 2
RS - Serbia 2
UG - Uganda 2
AL - Albania 1
BT - Bhutan 1
DK - Danimarca 1
GA - Gabon 1
GL - Groenlandia 1
HN - Honduras 1
HU - Ungheria 1
JO - Giordania 1
KE - Kenya 1
KG - Kirghizistan 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LI - Liechtenstein 1
LU - Lussemburgo 1
MC - Monaco 1
MD - Moldavia 1
MM - Myanmar 1
MN - Mongolia 1
MO - Macao, regione amministrativa speciale della Cina 1
NG - Nigeria 1
NP - Nepal 1
RE - Reunion 1
SA - Arabia Saudita 1
SI - Slovenia 1
SL - Sierra Leone 1
Totale 24.599
Città #
Fairfield 1.754
Woodbridge 1.525
Chandler 1.487
Jacksonville 1.265
Houston 928
Ashburn 866
Cambridge 797
Nyköping 761
Seattle 691
Wilmington 595
Ann Arbor 565
Singapore 501
Lawrence 393
Roxbury 390
Nanjing 362
Bari 347
Des Moines 244
Beijing 227
Boardman 190
New York 188
Princeton 159
Inglewood 136
San Diego 103
Nanchang 88
Jiaxing 84
Helsinki 83
Shenyang 80
Hebei 79
Santa Clara 79
Brooklyn 71
Dublin 67
Dearborn 61
Milan 61
Paris 54
Los Angeles 52
Moscow 52
Brussels 51
London 51
Munich 47
Rome 44
Tianjin 43
Changsha 39
Redwood City 39
Hong Kong 34
Romola 34
Pune 28
Nuremberg 25
Guangzhou 24
Jakarta 24
Modugno 23
Shanghai 23
São Paulo 23
Padova 22
Council Bluffs 21
Norwalk 20
Auburn Hills 17
Jinan 16
Dong Ket 15
Napoli 15
Washington 15
Liverpool 14
Rio de Janeiro 14
Torino 14
Vienna 14
Hefei 13
Frankfurt am Main 12
Genoa 12
Ningbo 12
Prescot 12
Zhengzhou 12
Belo Horizonte 11
Brno 11
Buffalo 11
Falls Church 11
Redmond 11
Tashkent 11
Turin 11
Falkenstein 10
Hounslow 10
Verdellino 10
Wuhan 10
Ardabil 9
Edinburgh 9
Florence 9
Naples 9
Palermo 9
San Severo 9
Leawood 8
San Francisco 8
Simi Valley 8
Augusta 7
Brasília 7
Jinhua 7
New Bedfont 7
Porto Alegre 7
San Giovanni Rotondo 7
São Luís 7
Bologna 6
Boydton 6
Cutrofiano 6
Totale 16.469
Nome #
Correzione dell'ipofibrinogenemia acquisita con concentrato di fibrinogeno in bambini affetti da LLA in trattamento con Asparaginasi. L'esperienza di due centri AIEOP 385
Endothelial and Metabolic Function Interactions in Overweight/Obese Children. 207
Combined microRNA and mRNA expression analysis in pediatric multiple sclerosis: an integrated approach to uncover novel pathogenic mechanisms of the disease. 158
Association between miRNAs expression and cognitive performances of Pediatric Multiple Sclerosis patients: A pilot study 154
Lupus anticoagulant, anticardiolipin antibodies and hepatitis C virus infection in thalassaemia 140
Cognitive, emotional, and behavioral profile in children and adolescents with chronic pain associated with rheumatic diseases: A case-control study 133
Association of congenital afibrinogenemia and k-dependent protein C deficiency - a case report 129
Thromboembolic risk in children with nephrotic syndrome 128
Lupus anticoagulant, anticardiolipin antibodies and hepatitis C virus infection in thalassaemia 121
DETERMINATION OF von WILLEBRAND FACTOR AND FACTOR XIII IN CHILDREN WITH SCHONLEIN HENOCH SYNDROME 118
Von Willebrand factor and factor XIII in children with Henoch-Schonlein purpura 117
Coagulation inhibitors (protein C and antithrombin III) in the preterm infant during the first month of life 116
Metabolic syndrome in childhood leukemia survivors: a meta-analysis 116
Carotenoids and Cardiovascular Risk 115
Vascular Function and Myocardial Performance Indices in Children Born Small for Gestational Age. 115
A Narrative Approach to Describe QoL in Children With Chronic ITP 115
Using pharmacokinetics for tailoring prophylaxis in people with hemophilia switching between clotting factor products: A scoping review 115
Serum D vitamin levels in children with immune thrombocytopenia 115
Consensus statements on vaccination in patients with haemophilia-Results from the Italian haemophilia and vaccinations (HEVA) project 115
Porpora trombocitopenica idiopatica (immune) (PTI) acuta in età pediatrica.Linee guida AIEOP per la diagnosi ed il trattamento 114
Thrombin generation in children with acute lymphoblastic leukemia (ALL): effects of ALL immunophenotypic subgroup on inherited thrombotic risk factors 113
B-cell hyperfunction in children with immune thrombocytopenic purpura persists after splenectomy 110
Creazione del network italiano Asplenia per la gestione coordinata a livello nazionale dei pazienti asplenici: il ruolo dell'AIEOP e di altre società scientifiche 110
Uric acid: from a biological advantage to a potential danger. A focus on cardiovascular effects 109
Non-alcoholic fatty liver disease is associated with early left ventricular dysfunction in childhood acute lymphoblastic leukaemia survivors. 109
Authors' Reply to "CD10 in the Cytological Diagnosis of Endobronchial Endometriosis" 108
Can Anti-Thyroid Antibodies Influence the Outcome of Primary Chronic Immune Thrombocytopenia in Children? 108
Vaccine administration and the development of immune thrombocytopenic purpura in children 105
Are all cases of paediatric essential thrombocythaemia really myeloproliferative neoplasms? Analysis of a large cohort 105
Issues in pediatric haemophilia care 104
Risk factors for subclinical atherosclerosis in diabetic and obese children 103
Analysis of Circulating Mediators of Bone Remodeling in Prader-Willi Syndrome 103
Human Fibrinogen Concentrate and Fresh Frozen Plasma in the Management of Severe Acquired Hypofibrinogenemia in Children with Acute Lymphoblastic Leukemia: Results of a Retrospective Survey 103
APC resistance in thalassemic patients:an under-lying cause of thrombosis 102
A polycentric, randomized, parallel-group, study on Lertal®, a multicomponent nutraceutical, as preventive treatment in children with allergic rhinoconjunctivitis: phase II 102
Coagulation and fibrinolytic systems in the ill preterm newborn 101
APC Resistance in thalassemic patients and under-lying cause of thrombosis 100
Thromboembolic risk in children with nephrotic syndrome 100
New data from the Italian National Register of Congenital Coagulopathies, 2016 Annual Survey 99
Effect of eradication of Helicobacter pylori in children with chronic immune thrombocytopenia: a prospective, controlled, multicenter study. 98
Pain assessment and management in haemophilia: A survey among Italian patients and specialist physicians 98
Autoimmune haematological disorders in two Italian children with Kabuki Syndrome 97
Cardiovascular dysfunction and vitamin D status in childhood acute lymphoblastic leukemia survivors 97
Uniparental disomy and pretreatment IGF-1 may predict elevated IGF-1 levels in Prader-Willi patients on GH treatment 97
Thrombin activation in thalassemia major: effect of iron chelators and splenectomy 96
How Physical Activity across the Lifespan Can Reduce the Impact of Bone Ageing: A Literature Review. 96
Catheter-related infections in pediatric patients with cancer. 95
Idiopathic neutropenia of infancy: Data from the Italian Neutropenia Registry 95
Bodyweight-adjusted rivaroxaban for children with venous thromboembolism (EINSTEIN-Jr): results from three multicentre, single-arm, phase 2 studies 95
Impact of sleep respiratory disorders on endothelial function in children. 94
Alterazioni coagulative e fibrinolitiche nel neonato pretermine affetto da: IRDS, asfissia alla nascita, sepsi 94
Chronic immune thrombocytopenia in childhood 94
Afibrinogenemia congenita associata a deficit di PC K-dipendente 94
A practical approach to the use of low molecular weight heparins in VTE treatment and prophylaxis in children and newborns. 94
Organizing national responses for rare blood disorders: the Italian experience with sickle cell disease in childhood. 93
Hereditary hemorrhagic telangiectasia: arteriovenous malformations in children. 93
Bleeding management in pediatric patients. 93
Contemporary deficiency of vitamin K-dependents procoagulants and anticoagulants (PC) in late hemorrhagic disease of newborn 93
The role of endothelial dysfunction and oxidative stress in cerebrovascular diseases 93
Clinical Data of Neonatal Systemic Thrombosis 92
Endothelial dysfunction and cardiovascular risk factors in childhood acute lymphoblastic leukemia survivors Autori 92
Alagille syndrome: A novel mutation in JAG1 gene 92
Metabolic, inflammatory, endothelial and haemostatic markers in a group of Italian obese children and adolescents 91
Validation of the ISTH/SSC bleeding assessment tool for inherited platelet disorders: a communication from the Platelet Physiology SSC 91
Platelet size for distinguishing between inherited thrombocytopenias and immune thrombocytopenia: a multicentric, real life study 90
Long-term follow-up analysis after rituximab therapy in children with refractory symptomatic ITP: identification of factors predictive of a sustained response 90
Coagulation inhibitors (PC and ATIII) in preterm infants during the first month of life 89
ANKRD26-related thrombocytopenia and myeloid malignancies. 89
Rituximab (anti-CD20 monoclonal antibody) in children with chronic refractory symptomatic immune thrombocytopenic purpura: efficacy and safety of treatment 89
K-dependent coagulant and anticoagulant factors deficiency in late haemorrhagic disease of the newborn 89
Present and Future of Pediatric Hemophilia Treatment 88
Resistance to activated protein C in thalassaemic patients: an underlying cause of thrombosis 88
Guidelines for the use of long-term central venous catheter in children with hemato-oncological disorders. On behalf of supportive therapy working group of Italian Association of Pediatric Hematology and Oncology (AIEOP) 87
APC resistance in thalassemic patients 87
Mechanisms of enhanced osteoclastogenesis in Alkaptonuria 86
Analysis of coagulation and fibrinolysis parameters in obese children and adolescents 86
Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial 86
Thromboembolic risk in children with nephrotic syndrom. 85
null 85
HHT in childhood: screening for special patients 85
ITP-QoL Questionnaire for Children with Immune Thrombocytopenia: Italian Version validation's 84
Neonatal bacterial meningitis: a systematic review of European available data 84
Afibrinogenemia congenita associata a deficit di PC K-dipendente 83
Hepatic angiodynamic profile in paediatric patients with hereditary haemorrhagic telangiectasia type 1 and type 2 83
Rituximab unveils hypogammaglobulinemia and immunodeficiency in children with autoimmune cytopenia 83
Unbalanced coagulation-fibrinolysis potential during L-Asparaginase therapy in children with acute lymphoblastic leukaemia 82
A volleyball player with bilateral knee osteochondritis dissecant treated with extracorporeal shock wave therapy 82
Monoclonal gammopathy of undetermined significance in pediatric kidney transplant: a possible role of Epstein-Barr virus. 82
Splenectomy in children with chronic ITP: Long-term efficacy and relation between its outcome and responses to previous treatments 82
Management of liver disease in thalassemia: main drug targets for a correct therapy 82
Prospective study of hemostatic alterations in children with acute lymphoblastic leukemia 82
Effects of deferiprone on immune status and cytokine pattern in thalassaemia major 81
Association of interleukin-(IL)10 haplotypes and serum IL-10 levels in the progression of childhood immune thrombocytopenic purpura. 81
Assetto immunitario e marcatori endoteliali nella vasculite di Schonlein-Henoch in età pediatrica 81
Protein C deficiency in two children with cerebral thrombosis 81
Analisi di parametri di coagulazione e fibrinolisi in bambini e adolescenti obesi 81
Thrombin generation in children with acute lymphoblastic leukemia: effect of leukemia immunophenotypic subgroups 81
La proteina Z e i PIVKA II in età neonatale 80
Successful treatment with Protein C of febrile neutropenia in pediatric patients during cancer therapy 80
Acute childhood idiopathic thrombocytopenic purpura: AIEOP consensus guidelines for diagnosis and treatment 80
Totale 10.211
Categoria #
all - tutte 115.764
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 115.764


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020936 0 0 0 0 0 0 0 0 0 270 507 159
2020/20213.096 329 180 266 223 358 137 282 269 296 381 197 178
2021/20222.866 149 523 46 187 82 108 115 182 154 114 457 749
2022/20233.994 627 383 252 371 505 524 59 421 648 28 95 81
2023/20241.364 116 283 72 147 113 324 41 55 26 37 19 131
2024/20253.281 178 103 670 219 166 566 409 512 299 159 0 0
Totale 25.565